AI set to revolutionize MS diagnosis and monitoring

NCT ID NCT06280755

Recruiting now Knowledge-focused Sponsor: icometrix Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gathers health data from 7,000 people with multiple sclerosis (MS) and related conditions. The goal is to use this information to train artificial intelligence (AI) tools that can help doctors diagnose MS earlier and predict how the disease will progress. No new treatments are being tested; instead, researchers are building a large database to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY ISOLATED SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Disease Progression multiple sclerosis myelin oligodendrocyte glycoprotein antibody-associated disease neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICALLY ISOLATED SYNDROME MULTIPLE SCLEROSIS MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE NMO SPECTRUM DISORDER RADIOLOGICALLY ISOLATED SYNDROME

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ERC Charité - Universitätsmedizin Berlin
RECRUITING

Berlin, State of Berlin, 131256, Germany

Contact
General University Hospital Prague
RECRUITING

Prague, Praha 2, 128 00, Czechia

Contact
Katholisches Klinikum Bochum - St. Joseph-Hospital
RECRUITING

Bochum, Bochum, 44791, Germany

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.